Filed: 5/10/2023ACC: 0001104659-23-057966
📋 What this filing means
TEKLA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 177 equity positions with a total reported market value of $2.63B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
177
Positions
$2.63B
Total AUM (reported)
41.01M
Total Shares
Allocation by class
COMMON$2.32B88.3%
SPONSORED ADR$167.19M6.4%
SHARES$81.30M3.1%
CLASS A$24.41M0.9%
SPONSORED ADS$17.44M0.7%
S&P BIOTECH ETF$11.25M0.4%
NAMEN AKT$2.49M0.1%
Portfolio Concentration
Top 3$381.36M14.5%
4–10$660.75M25.2%
11–25$711.45M27.1%
Rest$873.06M33.2%
Top 3 weight
14.5%
Top 10 weight
39.7%
Voting Authority Distribution
Total shares with voting rights: 2.63B
Sole
Full voting authority
2.63B
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole177
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings177
Rows:
Amgen Inc.
SOLEShares555.94K
TypeSH
Market value$134.40M
5.12%
Sole
134.40M
Shared
0.00
None
0.00
Gilead Sciences, Inc.
SOLEShares1.56M
TypeSH
Market value$129.42M
4.93%
Sole
129.42M
Shared
0.00
None
0.00
Regeneron Pharmaceuticals, Inc.
SOLEShares143.05K
TypeSH
Market value$117.54M
4.48%
Sole
117.54M
Shared
0.00
None
0.00
Johnson & Johnson
SOLEShares721.78K
TypeSH
Market value$111.88M
4.26%
Sole
111.88M
Shared
0.00
None
0.00
Unitedhealth Group Inc.
SOLEShares234.17K
TypeSH
Market value$110.67M
4.21%
Sole
110.67M
Shared
0.00
None
0.00
Vertex Pharmaceuticals Inc.
SOLEShares330.34K
TypeSH
Market value$104.08M
3.96%
Sole
104.08M
Shared
0.00
None
0.00
Eli Lilly and Company
SOLEShares288.92K
TypeSH
Market value$99.22M
3.78%
Sole
99.22M
Shared
0.00
None
0.00
AbbVie Inc.
SOLEShares511.60K
TypeSH
Market value$81.53M
3.10%
Sole
81.53M
Shared
0.00
None
0.00
Illumina, Inc.
SOLEShares348.08K
TypeSH
Market value$80.95M
3.08%
Sole
80.95M
Shared
0.00
None
0.00
Pfizer Inc.
SOLEShares1.78M
TypeSH
Market value$72.42M
2.76%
Sole
72.42M
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares992.66K
TypeSH
Market value$68.90M
2.62%
Sole
68.90M
Shared
0.00
None
0.00
Biogen Inc.
SOLEShares240.93K
TypeSH
Market value$66.98M
2.55%
Sole
66.98M
Shared
0.00
None
0.00
Abbott Laboratories
SOLEShares623.86K
TypeSH
Market value$63.17M
2.41%
Sole
63.17M
Shared
0.00
None
0.00
Merck & Co., Inc.
SOLEShares552.12K
TypeSH
Market value$58.74M
2.24%
Sole
58.74M
Shared
0.00
None
0.00
Thermo Fisher Scientific Inc.
SOLEShares93.70K
TypeSH
Market value$54.01M
2.06%
Sole
54.01M
Shared
0.00
None
0.00
Elevance Health, Inc.
SOLEShares114.07K
TypeSH
Market value$52.45M
2.00%
Sole
52.45M
Shared
0.00
None
0.00
Moderna, Inc.
SOLEShares322.22K
TypeSH
Market value$49.49M
1.88%
Sole
49.49M
Shared
0.00
None
0.00
The Cigna Group
SOLEShares182.63K
TypeSH
Market value$46.67M
1.78%
Sole
46.67M
Shared
0.00
None
0.00
Bristol-Myers Squibb Company
SOLEShares663.80K
TypeSH
Market value$46.01M
1.75%
Sole
46.01M
Shared
0.00
None
0.00
Seagen Inc.
SOLEShares224.66K
TypeSH
Market value$45.49M
1.73%
Sole
45.49M
Shared
0.00
None
0.00
Sarepta Therapeutics, Inc.
SOLEShares285.65K
TypeSH
Market value$39.37M
1.50%
Sole
39.37M
Shared
0.00
None
0.00
argenx SE
SOLEShares88.31K
TypeSH
Market value$32.90M
1.25%
Sole
32.90M
Shared
0.00
None
0.00
IDEXX Laboratories, Inc.
SOLEShares58.59K
TypeSH
Market value$29.30M
1.12%
Sole
29.30M
Shared
0.00
None
0.00
BioMarin Pharmaceutical Inc.
SOLEShares300.09K
TypeSH
Market value$29.18M
1.11%
Sole
29.18M
Shared
0.00
None
0.00
Intuitive Surgical, Inc.
SOLEShares112.68K
TypeSH
Market value$28.79M
1.10%
Sole
28.79M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Amgen Inc.SOLE | Common | 555.94K | SH | $134.40M 5.12% | 134.40M | 0.00 | 0.00 |
Gilead Sciences, Inc.SOLE | Common | 1.56M | SH | $129.42M 4.93% | 129.42M | 0.00 | 0.00 |
Regeneron Pharmaceuticals, Inc.SOLE | Common | 143.05K | SH | $117.54M 4.48% | 117.54M | 0.00 | 0.00 |
Johnson & JohnsonSOLE | Common | 721.78K | SH | $111.88M 4.26% | 111.88M | 0.00 | 0.00 |
Unitedhealth Group Inc.SOLE | Common | 234.17K | SH | $110.67M 4.21% | 110.67M | 0.00 | 0.00 |
Vertex Pharmaceuticals Inc.SOLE | Common | 330.34K | SH | $104.08M 3.96% | 104.08M | 0.00 | 0.00 |
Eli Lilly and CompanySOLE | Common | 288.92K | SH | $99.22M 3.78% | 99.22M | 0.00 | 0.00 |
AbbVie Inc.SOLE | Common | 511.60K | SH | $81.53M 3.10% | 81.53M | 0.00 | 0.00 |
Illumina, Inc.SOLE | Common | 348.08K | SH | $80.95M 3.08% | 80.95M | 0.00 | 0.00 |
Pfizer Inc.SOLE | Common | 1.78M | SH | $72.42M 2.76% | 72.42M | 0.00 | 0.00 |
AstraZeneca PLCSOLE | Sponsored ADR | 992.66K | SH | $68.90M 2.62% | 68.90M | 0.00 | 0.00 |
Biogen Inc.SOLE | Common | 240.93K | SH | $66.98M 2.55% | 66.98M | 0.00 | 0.00 |
Abbott LaboratoriesSOLE | Common | 623.86K | SH | $63.17M 2.41% | 63.17M | 0.00 | 0.00 |
Merck & Co., Inc.SOLE | Common | 552.12K | SH | $58.74M 2.24% | 58.74M | 0.00 | 0.00 |
Thermo Fisher Scientific Inc.SOLE | Common | 93.70K | SH | $54.01M 2.06% | 54.01M | 0.00 | 0.00 |
Elevance Health, Inc.SOLE | Common | 114.07K | SH | $52.45M 2.00% | 52.45M | 0.00 | 0.00 |
Moderna, Inc.SOLE | Common | 322.22K | SH | $49.49M 1.88% | 49.49M | 0.00 | 0.00 |
The Cigna GroupSOLE | Common | 182.63K | SH | $46.67M 1.78% | 46.67M | 0.00 | 0.00 |
Bristol-Myers Squibb CompanySOLE | Common | 663.80K | SH | $46.01M 1.75% | 46.01M | 0.00 | 0.00 |
Seagen Inc.SOLE | Common | 224.66K | SH | $45.49M 1.73% | 45.49M | 0.00 | 0.00 |
Sarepta Therapeutics, Inc.SOLE | Common | 285.65K | SH | $39.37M 1.50% | 39.37M | 0.00 | 0.00 |
argenx SESOLE | Sponsored ADR | 88.31K | SH | $32.90M 1.25% | 32.90M | 0.00 | 0.00 |
IDEXX Laboratories, Inc.SOLE | Common | 58.59K | SH | $29.30M 1.12% | 29.30M | 0.00 | 0.00 |
BioMarin Pharmaceutical Inc.SOLE | Common | 300.09K | SH | $29.18M 1.11% | 29.18M | 0.00 | 0.00 |
Intuitive Surgical, Inc.SOLE | Common | 112.68K | SH | $28.79M 1.10% | 28.79M | 0.00 | 0.00 |
Page 1 of 8
…